Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion type Assertion NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_head.
- NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion description "[Moreover, TF overexpression accompanies features of cellular aggressiveness such as markers of CSCs (CD133), epithelial-to-mesenchymal transition (EMT) and expression of the angiogenic and prometastatic phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_provenance.
- NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion evidence source_evidence_literature NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_provenance.
- NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion SIO_000772 20434004 NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_provenance.
- NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion wasDerivedFrom befree-20140225 NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_provenance.
- NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_assertion wasGeneratedBy ECO_0000203 NP169666.RAClR1C6rtZk-qdOgZLIHa4HJzdmY3Z6XGY2s6XXD5uwk130_provenance.